Skip to main content
Top
Published in: Diabetology International 4/2012

01-12-2012 | Original article

Whole gene deletion mutation of HNF1B and exonic aberration mutations of GCK and HNF1B in patients with MODY in Japan

Authors: Miho Takizawa, Naoko Iwasaki, Toshiyuki Yamamoto, Yasuko Uchigata, Yasuhiko Iwamoto

Published in: Diabetology International | Issue 4/2012

Login to get access

Abstract

Aims

Recent reports indicate that genomic rearrangements are novel causative mutations for maturity onset diabetes of the young (MODY). The aim of this study was to investigate genomic rearrangements in Japanese patients with MODY.

Methods

Subjects diagnosed with diabetes before the age of 30 years and clinically suspected of having MODY but without identified causative mutations were included in the study (n = 223). Multiplex ligation-dependent probe amplification (MLPA) assays were performed to detect genomic rearrangements in HNF4A, GCK, HNF1A, and HNF1B. Array comparative genomic hybridization (aCGH) was performed to confirm the presence and extent of complete gene deletion or duplications. To examine variation in exon copy number, a custom MODY-CGH microarray using the web-based Agilent eArray database was performed.

Results

Four subjects with a hemizygous deletion mutation at 17q12, including HNF1B and spanning 1.4 Mb, were identified. The clinical features of these patients corresponded to those of MODY5 patients. In addition, one case each with an exon copy number variation of GCK7 and HNF1B3 were identified by MLPA and confirmed by array CGH.

Conclusions

We identified four Japanese MODY cases with a genomic rearrangement in MODY5. Our data indicate that when diagnosing MODY5, the typical phenotype is more important than the family history because the cases detected occurred de novo. Moreover, we report the first Japanese cases with exonic copy number variation of the genes for MODY2 and 5.
Literature
1.
go back to reference Tattersall RB. Mild familial diabetes with dominant inheritance. Q J Med. 1974;43(170):339–57.PubMed Tattersall RB. Mild familial diabetes with dominant inheritance. Q J Med. 1974;43(170):339–57.PubMed
2.
go back to reference Tattersall RB, Fajans SS. A difference between the inheritance of classical juvenile-onset and maturity onset type of young people. Diabetes. 1975;24(1):44–53.PubMedCrossRef Tattersall RB, Fajans SS. A difference between the inheritance of classical juvenile-onset and maturity onset type of young people. Diabetes. 1975;24(1):44–53.PubMedCrossRef
3.
go back to reference Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P, Permutt MA, Beckmann JS, Bell GI, Cohen D. Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. N Engl J Med. 1993;328(10):697–702.PubMedCrossRef Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P, Permutt MA, Beckmann JS, Bell GI, Cohen D. Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. N Engl J Med. 1993;328(10):697–702.PubMedCrossRef
4.
go back to reference Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj VV, Chen X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigori H, Takeda J, Fajans SS, Hattersley AT, Iwasaki N, Hansen T, Pedersen O, Polonsky KS, Turner RC, Velho G, Chevre JC, Froguel P, Bell GI. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature. 1996;384(6608):455–8.PubMedCrossRef Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj VV, Chen X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigori H, Takeda J, Fajans SS, Hattersley AT, Iwasaki N, Hansen T, Pedersen O, Polonsky KS, Turner RC, Velho G, Chevre JC, Froguel P, Bell GI. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature. 1996;384(6608):455–8.PubMedCrossRef
5.
go back to reference Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn BN, Lindner T, Yamagata K, Ogata M, Tomonaga O, Kuroki H, Kasahara T, Iwamoto Y, Bell GI. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet. 1997;17(4):384–5.PubMedCrossRef Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn BN, Lindner T, Yamagata K, Ogata M, Tomonaga O, Kuroki H, Kasahara T, Iwamoto Y, Bell GI. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet. 1997;17(4):384–5.PubMedCrossRef
6.
go back to reference Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature. 1996;384(6608):458–60.PubMedCrossRef Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature. 1996;384(6608):458–60.PubMedCrossRef
7.
go back to reference Stoffers DA, Ferrer J, Clarke WL, Habener JF. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet. 1997;17(2):138–9.PubMedCrossRef Stoffers DA, Ferrer J, Clarke WL, Habener JF. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet. 1997;17(2):138–9.PubMedCrossRef
8.
go back to reference Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T, Saad M, Warram JH, Montminy M, Krolewski AS. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet. 1999;23(3):323–8.PubMedCrossRef Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T, Saad M, Warram JH, Montminy M, Krolewski AS. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet. 1999;23(3):323–8.PubMedCrossRef
9.
go back to reference Frayling TM, Evans JC, Bulman MP, Pearson E, Allen L, Owen K, Bingham C, Hannemann M, Shepherd M, Ellard S, Hattersley AT. Beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes. 2001;50(Suppl 1):S94–100.PubMedCrossRef Frayling TM, Evans JC, Bulman MP, Pearson E, Allen L, Owen K, Bingham C, Hannemann M, Shepherd M, Ellard S, Hattersley AT. Beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes. 2001;50(Suppl 1):S94–100.PubMedCrossRef
10.
go back to reference Ledermann HM. Is maturity onset diabetes at young age (MODY) more common in Europe than previously assumed? Lancet. 1995;345(8950):648.PubMedCrossRef Ledermann HM. Is maturity onset diabetes at young age (MODY) more common in Europe than previously assumed? Lancet. 1995;345(8950):648.PubMedCrossRef
11.
go back to reference Otani T, Yao K, Sato A, Iwasaki N, Higami Y, Kasahara T, Hirata Y. Inheritance of diabetes and clinical features in patients with non-insulin dependent diabetes (NIDDM) diagnosed before age of 25 years. J Jpn Diabetes Soc. 1987;30(8):739–46. Otani T, Yao K, Sato A, Iwasaki N, Higami Y, Kasahara T, Hirata Y. Inheritance of diabetes and clinical features in patients with non-insulin dependent diabetes (NIDDM) diagnosed before age of 25 years. J Jpn Diabetes Soc. 1987;30(8):739–46.
12.
go back to reference Chèvre JC, Hani EH, Boutin P, Vaxillaire M, Blanché H, Vionnet N, Pardini VC, Timsit J, Larger E, Charpentier G, Beckers D, Maes M, Bellanné-Chantelot C, Velho G, Froguel P. Mutation screening in 18 Caucasian families suggest the existence of other MODY genes. Diabetologia. 1998;41(9):1017–23.PubMedCrossRef Chèvre JC, Hani EH, Boutin P, Vaxillaire M, Blanché H, Vionnet N, Pardini VC, Timsit J, Larger E, Charpentier G, Beckers D, Maes M, Bellanné-Chantelot C, Velho G, Froguel P. Mutation screening in 18 Caucasian families suggest the existence of other MODY genes. Diabetologia. 1998;41(9):1017–23.PubMedCrossRef
13.
go back to reference Stride A, Hattersley AT. Different genes, different diabetes: lessons from maturity-onset diabetes of the young. Ann Med. 2002;34(3):207–16.PubMed Stride A, Hattersley AT. Different genes, different diabetes: lessons from maturity-onset diabetes of the young. Ann Med. 2002;34(3):207–16.PubMed
14.
go back to reference Bellanné-Chantelot C, Clauin S, Chauveau D, Collin P, Daumont M, Douillard C, Dubois-Laforgue D, Dusselier L, Gautier JF, Jadoul M, Laloi-Michelin M, Jacquesson L, Larger E, Louis J, Nicolino M, Subra JF, Wilhem JM, Young J, Velho G, Timsit J. Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. Diabetes. 2005;54(11):3126–32.PubMedCrossRef Bellanné-Chantelot C, Clauin S, Chauveau D, Collin P, Daumont M, Douillard C, Dubois-Laforgue D, Dusselier L, Gautier JF, Jadoul M, Laloi-Michelin M, Jacquesson L, Larger E, Louis J, Nicolino M, Subra JF, Wilhem JM, Young J, Velho G, Timsit J. Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. Diabetes. 2005;54(11):3126–32.PubMedCrossRef
15.
go back to reference Ellard S, Thomas K, Edghill EL, Owens M, Ambye L, Cropper J, Little J, Strachan M, Stride A, Ersoy B, Eiberg H, Pedersen O, Shepherd MH, Hansen T, Harries LW, Hattersley AT. Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young. Diabetologia. 2007;50(11):2313–7.PubMedCrossRef Ellard S, Thomas K, Edghill EL, Owens M, Ambye L, Cropper J, Little J, Strachan M, Stride A, Ersoy B, Eiberg H, Pedersen O, Shepherd MH, Hansen T, Harries LW, Hattersley AT. Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young. Diabetologia. 2007;50(11):2313–7.PubMedCrossRef
16.
go back to reference Carette C, Vaury C, Barthélémy A, Clauin S, Grünfeld JP, Timsit J, Bellanné-Chantelot C. Exonic duplication of the hepatocyte nuclear factor-1beta gene (transcription factor 2, hepatic) as a cause of maturity onset diabetes of the young type 5. J Clin Endocrinol Metab. 2007;92(7):2844–7.PubMedCrossRef Carette C, Vaury C, Barthélémy A, Clauin S, Grünfeld JP, Timsit J, Bellanné-Chantelot C. Exonic duplication of the hepatocyte nuclear factor-1beta gene (transcription factor 2, hepatic) as a cause of maturity onset diabetes of the young type 5. J Clin Endocrinol Metab. 2007;92(7):2844–7.PubMedCrossRef
17.
go back to reference Aoki E, Takizawa M, Yanagisawa K, Harada M, Hanai K, Ishii A, Yago R, Iwasaki N, Iwamoto Y. A case of MODY5 associated with a complicated urinary tract infection. J Tokyo Women’s Med Univ. 2011;81:E247–52. Aoki E, Takizawa M, Yanagisawa K, Harada M, Hanai K, Ishii A, Yago R, Iwasaki N, Iwamoto Y. A case of MODY5 associated with a complicated urinary tract infection. J Tokyo Women’s Med Univ. 2011;81:E247–52.
18.
go back to reference Raile K, Klopocki E, Holder M, Wessel T, Galler A, Deiss D, Müller D, Riebel T, Horn D, Maringa M, Weber J, Ullmann R, Grüters A. Expanded clinical spectrum in hepatocyte nuclear factor 1b-maturity-onset diabetes of the young. J Clin Endocrinol Metab. 2009;94(7):2658–64.PubMedCrossRef Raile K, Klopocki E, Holder M, Wessel T, Galler A, Deiss D, Müller D, Riebel T, Horn D, Maringa M, Weber J, Ullmann R, Grüters A. Expanded clinical spectrum in hepatocyte nuclear factor 1b-maturity-onset diabetes of the young. J Clin Endocrinol Metab. 2009;94(7):2658–64.PubMedCrossRef
19.
go back to reference Oram RA, Edghill EL, Blackman J, Taylor MJ, Kay T, Flanagan SE, Ismail-Pratt I, Creighton SM, Ellard S, Hattersley AT, Bingham C. Mutations in the hepatocyte nuclear factor-1beta (HNF1B) gene are common with combined uterine and renal malformations but are not found with isolated uterine malformations. Am J Obstet Gynecol. 2010;203(4):364.e1–5.CrossRef Oram RA, Edghill EL, Blackman J, Taylor MJ, Kay T, Flanagan SE, Ismail-Pratt I, Creighton SM, Ellard S, Hattersley AT, Bingham C. Mutations in the hepatocyte nuclear factor-1beta (HNF1B) gene are common with combined uterine and renal malformations but are not found with isolated uterine malformations. Am J Obstet Gynecol. 2010;203(4):364.e1–5.CrossRef
20.
go back to reference Saillour Y, Cossée M, Leturcq F, Vasson A, Beugnet C, Poirier K, Commere V, Sublemontier S, Viel M, Letourneur F, Barbot JC, Deburgrave N, Chelly J, Bienvenu T. Detection of exonic copy-number changes using a highly efficient oligonucleotide-based comparative genomic hybridization-array method. Hum Mutat. 2008;29(9):1083–90.PubMedCrossRef Saillour Y, Cossée M, Leturcq F, Vasson A, Beugnet C, Poirier K, Commere V, Sublemontier S, Viel M, Letourneur F, Barbot JC, Deburgrave N, Chelly J, Bienvenu T. Detection of exonic copy-number changes using a highly efficient oligonucleotide-based comparative genomic hybridization-array method. Hum Mutat. 2008;29(9):1083–90.PubMedCrossRef
21.
go back to reference Marini C, Scheffer IE, Nabbout R, Mei D, Cox K, Dibbens LM, McMahon JM, Iona X, Carpintero RS, Elia M, Cilio MR, Specchio N, Giordano L, Striano P, Gennaro E, Cross JH, Kivity S, Neufeld MY, Afawi Z, Andermann E, Keene D, Dulac O, Zara F, Berkovic SF, Guerrini R, Mulley JC. SCN1A duplications and deletions detected in Dravet syndrome: implications for molecular diagnosis. Epilepsia. 2009;50(7):1670–8.PubMedCrossRef Marini C, Scheffer IE, Nabbout R, Mei D, Cox K, Dibbens LM, McMahon JM, Iona X, Carpintero RS, Elia M, Cilio MR, Specchio N, Giordano L, Striano P, Gennaro E, Cross JH, Kivity S, Neufeld MY, Afawi Z, Andermann E, Keene D, Dulac O, Zara F, Berkovic SF, Guerrini R, Mulley JC. SCN1A duplications and deletions detected in Dravet syndrome: implications for molecular diagnosis. Epilepsia. 2009;50(7):1670–8.PubMedCrossRef
Metadata
Title
Whole gene deletion mutation of HNF1B and exonic aberration mutations of GCK and HNF1B in patients with MODY in Japan
Authors
Miho Takizawa
Naoko Iwasaki
Toshiyuki Yamamoto
Yasuko Uchigata
Yasuhiko Iwamoto
Publication date
01-12-2012
Publisher
Springer Japan
Published in
Diabetology International / Issue 4/2012
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-012-0084-9

Other articles of this Issue 4/2012

Diabetology International 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine